Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

(Reuters) ​-Abbott ‌said on ‌Thursday it would buy cancer ⁠test ‌maker Exact Sciences in ‍up to $23 billion ​deal, ‌bolstering the medical device maker’s diagnostics ⁠business.

​(​Reporting by Padmanabhan Ananthan ‍and ⁠Siddhi Mahatole in Bengaluru;⁠ Editing ‌by Shilpi ‌Majumdar)